Correlation Between 180 Life and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both 180 Life and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 180 Life and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 180 Life Sciences and Kiromic Biopharma, you can compare the effects of market volatilities on 180 Life and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 180 Life with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 180 Life and Kiromic Biopharma.
Diversification Opportunities for 180 Life and Kiromic Biopharma
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 180 and Kiromic is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding 180 Life Sciences and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and 180 Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 180 Life Sciences are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of 180 Life i.e., 180 Life and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between 180 Life and Kiromic Biopharma
If you would invest 268.00 in Kiromic Biopharma on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Kiromic Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.35% |
| Values | Daily Returns |
180 Life Sciences vs. Kiromic Biopharma
Performance |
| Timeline |
| 180 Life Sciences |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
180 Life and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 180 Life and Kiromic Biopharma
The main advantage of trading using opposite 180 Life and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 180 Life position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| 180 Life vs. Zura Bio Limited | 180 Life vs. Phio Pharmaceuticals Corp | 180 Life vs. Sonnet Biotherapeutics Holdings | 180 Life vs. Cardio Diagnostics Holdings |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |